Research Article
rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
Table 1
Demographic and biochemical characteristics of the whole study group.
| | Study group |
| Age (years) | | Gender (F/M) | 30/54 | Mean plasma viscosity (mPas) | | MHD duration (months) | | Mean serum Hb level (g/dL) | | Mean serum WBC count (/µL) | | Mean serum Plt count (/µL) | | Median serum PTH level (pg/mL) | 397.85 (498.30) | Mean serum Ca level (mg/dL) | | Mean serum P level (mg/dL) | | Mean Ca P product | | Mean serum CRP level (mg/L) | | Mean serum albumin level (g/dL) | | Median serum ferritin level (ng/mL) | 531.00 (331.50) | Total parenteral iron therapy (U/12 months) | 20000 (3000) | Total rHuEPO usage (U/kg/week) | 295.00 (422.35) | rHuEPO/Hb | |
|
|